H.R. 1794: United States-Abraham Accords Cooperation and Security Act of 2025

This bill, titled the United States-Abraham Accords Cooperation and Security Act of 2025, aims to establish a new office within the Food and Drug Administration (FDA) called the Abraham Accords Office. The primary goals of this office are to enhance regulatory cooperation and oversight related to medical products among countries that are part of the Abraham Accords, which are diplomatic agreements involving several Middle Eastern nations and Israel.

Establishment of the Office

The bill mandates the Secretary of Health and Human Services to create the Abraham Accords Office within the FDA. This office will have a director and will be supported by FDA personnel as needed. The establishment process involves:

• Selecting a location for the office in one of the Abraham Accords countries through consultation with relevant U.S. government officials and partners in those countries.
• Assigning personnel to fulfill the office's responsibilities.

Duties of the Office

The Abraham Accords Office will be responsible for several key activities:

• Providing technical assistance to regulatory partners in countries that signed the Abraham Accords. This includes helping these countries strengthen their regulatory frameworks, particularly for medical products.
• Facilitating communication and interaction between the FDA and stakeholders in Abraham Accords countries. This involves sharing information regarding U.S. regulatory processes and providing feedback on the development and manufacturing of medical products.
• Carrying out any additional activities deemed necessary by the Secretary to fulfill the office’s mission.

Report to Congress

Within three years of the office's establishment, the Secretary of Health and Human Services is required to submit a report to Congress. This report will include:

• An evaluation of the office’s effectiveness in aiding manufacturers in Abraham Accords countries to meet FDA regulatory requirements.
• A count of the interactions facilitated by the office with various parties.
• A summary of the technical assistance provided to regulatory partners.
• Recommendations for improving coordination between the FDA and entities in Abraham Accords countries.

Definition of Abraham Accords Country

The bill defines "Abraham Accords country" as any nation that has signed the Abraham Accords Declaration, as recognized by the U.S. Department of State.

National Security Consideration

It is noted in the bill that nothing in this legislation should contradict national security recommendations from the Federal Government.

Relevant Companies